Reply to Ding et al.: Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment

Am J Respir Crit Care Med. 2025 Jun 13. Online ahead of print.

Alexander Mk Rothman^{1

2

3}, Sofia Villar^{4

5}, Martin Law⁶, Martin R Wilkins⁷

¹ The University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, United Kingdom of Great Britain and Northern Ireland.
² Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom of Great Britain and Northern Ireland.
³ The University of Sheffield, INSIGNEO, Institute for In Silico Medicine, Sheffield, United Kingdom of Great Britain and Northern Ireland.
⁴ Papworth Hospital NHS Foundation Trust, Research and Development, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.
⁵ MRC Biostatistics Unit, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.
⁶ Cambridge Institute of Public Health, MRC Biostatistics Unit, Cambridge, United Kingdom of Great Britain and Northern Ireland.
⁷ Imperial College London, London, United Kingdom of Great Britain and Northern Ireland; m.wilkins@imperial.ac.uk.

No abstract available

Keywords: imatinib; pulmonary hypertension; treatment.